1Zilla P, Brink J, Human P. Prosthetic heart valves: Catering for the few[J]. Biomaterials, 2008, 29 (4) :385 - 406.
2Krahn AD, Healey JS, Simpson CS, et al. Anticoagulation of patients on chronic warfarin undergoing an'hythmia device surgery: wide variability of perioperative bridging in Canada [ J ]. Heart Rhythm, 2009, 6(9):1276- 1279.
3Ennker JA, Ennker IC, Albert AA, et al. Florath I. The Freestyle stentless bioprosthesis in more than 1000 patienls: a single-center experience over 10 years[J]. J Card Surg, 2009, 24( 1 ) :41 -48.
4Borger MA, Carson SM, lvanov J, et al. Stentless aortic valves are hemodynamically superior to stented valves during midterm followup : a large rest respective study [ J ]. Ann Thorac Surg, 2005, 80 (6) :2180 -2185.
5Pavoni D, Badano LP, lus F, et al. Limited long-term durability of the Cryolife O'Brien stentlcss porcine xenograft valve [ J 1. Circztlation, 2007, 116 (11 Suppl):1307-1313.
6Gross JM, Calcification of bioprosthetie heart valve and its assessment [J].J Thorae Cardiovasc Surg, 2001 , 121 ( 3 ) :428 - 430.
7Eberl T, Siedler S, Sehumacher B, et al. Experimental in vitro endothelialization of cardiac valve leaflets [ J ]. Ann Thorac Surg, 1992, 53(3) :487 -492.
4Korossis SA,Booth C,Wilcox HE,et al.Tissue engineering of cardiac valve prostheses Ⅱ;b characterization of an aceuular porcine iomechanical characterization of decellualrized porcine aortic heart valves.J Heart Valve Dis,2002,11:463-471.
5Fuchs JR,Nasseri BA,Vacanti JP.Tissue engineering:A 21st century solution to surgical reconstruction.Ann Thorac Surg, 2001, 72:577-591.
6Steinhoff G, Stock U,Karim N,et al.Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits. Circulation,2000, 102:Ⅲ-50.
7Jorge-Herrero E,Fernandez P,Gutierrez M,et al.Study of the calcification of bovine pericardium:analysis of the implication of lipids and proteoglycans.Biomaterials, 1991,12:683-687.
8Jackson RL,Busch SJ,Cardin AD.Glycosaminoglycans:molecularproperties,protein interactions,and role in physiologicalprocesses.Physiol Rev, 1991, 71:481-539.
9David RC,Robert ML,You SS,et al.Transformation of nonv ascular acellular tissue matrices into durable vascular conduits.Ann Thorac Surg, 2001,71:s433-436.
10Coito AJ,Kupiec-Weglinski JW.Extracellular matrix proteins:by standers or active participants in the allograft rejection cascade? Ann Transplant, 1996, 1:14-18.
7Phillips SJ. Searching for the truth: a mechanical or a tissue valve ? J Heart Valve Dis, 2004, 13 (Supp 11 ) : S95-S98.
8Suttie SA, Jamieson WR, Burr LH, et al. Elderly valve replacement with bioprostheses and mechanical prostheses. Comparison by com- posites of complications. J Cardiovase Surg (Torino), 2006, 47 (2) : 191-199.
9Bussey HI. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves. J Heart Valve Dis, 2004, 13 (3) : 319-324.
10Julie R, Boris AN, Vacanti JP. Tissue engineering: a 21st centurysolution to surgical reconstructtion[J]. Ann Thorac Surg, 2001, 72(2):577-591.
